Natriumcromoglicaat Bb (Sodium Cromoglicate)

Sodium Cromoglicate, the active ingredient in Natriumcromoglicaat Bb, is a mast cell stabilizer presented as an oral formulation for systemic use. It is employed to prevent asthma attacks, reduce allergic rhinitis symptoms, manage mastocytosis, and avert exercise‑induced bronchospasm in patients requiring prophylactic antiallergic therapy and improve overall respiratory health under medical supervision and through regular dosing.

GNH USA supplies Natriumcromoglicaat Bb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with a focus on quality assurance and regulatory compliance.

Sodium Cromoglicate is used to manage allergic and mast‑cell mediated respiratory conditions. - Asthma prophylaxis: reduces frequency and severity of bronchospasm episodes. - Allergic rhinitis: alleviates nasal congestion, sneezing and itching. - Mastocytosis: helps control systemic mast‑cell activation symptoms. - Exercise‑induced bronchospasm: prevents airway narrowing during physical activity.

Sodium Cromoglicate may be associated with several adverse reactions, ranging from mild to serious. Common Side Effects: - Mouth irritation: transient burning or tingling sensation. - Nausea: mild gastrointestinal discomfort. - Headache: mild to moderate intensity. Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Severe bronchospasm: paradoxical worsening of airway obstruction. - Hepatotoxicity: abnormal liver enzyme elevations.

When prescribing Sodium Cromoglicate, consider the following precautions. - Renal impairment: adjust dose or monitor renal function. - Concurrent asthma therapy: do not replace rescue inhalers. - Pregnancy: use only if clearly needed after risk‑benefit assessment. - Elderly: monitor for increased sensitivity to adverse effects. - Drug interactions: review concomitant mast cell stabilizers. - Store at ambient temperature: keep in the original container, protect from moisture.

Sodium Cromoglicate can interact with other medicines; awareness of the level of interaction helps manage risk. Major Interactions (Avoid): - Beta‑agonists: may reduce the prophylactic efficacy of sodium cromoglicate. - Anticholinergic agents: increased risk of dry mouth and reduced tolerability. Moderate Interactions (Monitor Closely): - Theophylline: monitor plasma levels for possible alteration. - NSAIDs: may increase gastrointestinal irritation when combined. - ACE inhibitors: watch for additive cough symptoms.